Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was honored with the “Best CDMO in Automated Aseptic Filling” award at the Taiwan Biopharma Excellence Awards 2025, held yesterday (March 26) at the Hilton Taipei Sinban. Organized by the renowned international consulting firm IMAPAC, the award recognizes Amaran Biotech’s outstanding contribution to advancing automated aseptic filling solutions in the biopharmaceutical sector. 

The Taiwan Biopharma Excellence Awards celebrate organizations, technologies, and experts that drive innovation and excellence in biomanufacturing and research—delivering faster, cost-effective, and higher-quality solutions to accelerate the advancement of the biopharmaceutical industry. The award ceremony was held alongside IMAPAC’s 12th Biologics World Taiwan 2025 and 4th Stem Cells & Regenerative Medicine Asia 2025, gathering nearly 300 leading professionals from Taiwan’s top biopharmaceutical, vaccine manufacturing, and biologics companies. 

Amaran Biotech successfully introduced Taiwan’s first fully automated aseptic filling line in 2022. Utilizing the Cytiva (Vanrx) SA25 robotic aseptic filling system, the company has significantly reduced the risk of human intervention in the filling process, enhancing drug safety. This state-of-the-art technology provides high-quality, low-waste filling solutions for high-value biologics, including protein therapeutics, antibody drugs, and nanoparticle-based drug. This system supports various container types, including vials, pre-filled syringes, and cartridges, with an impressive filling accuracy of 99.99%. 

During her acceptance speech, Dr. Tessie Che, Chairperson and General Manager of Amaran Biotech, stated, “We are deeply honored to receive this prestigious recognition from IMAPAC. This award belongs to our entire team! When we made the decision to build our automated aseptic filling line in 2020, the Covid-19 pandemic posed unprecedented challenges—international engineers were unable to travel to Taiwan for on-site installation. Nevertheless, through close remote collaboration with the equipment manufacturer, our team successfully completed the installation. We overcame every obstacle, ensuring our facility met stringent regulatory standards set by the FDA, EMA, ICH, PIC/S, and ISPE. Moving forward, Amaran Biotech is committed to leveraging high-tech innovation, including AI integration, to deliver comprehensive, customized CDMO services and become a global leader in pharmaceutical manufacturing.”

 【Caption 1】Amaran Biotech receives IMAPAC’s Taiwan Biopharma Excellence Award 2025, recognized as Best CDMO in Automated Aseptic Filling. From left: Award Presenter Dr. Kazuchika Furuishi, Dr. Tessie Che, Chairperson & General Manager at Amaran Biotech and Jasmine Yeh, Vice President, Finance & General Affairs at Amaran Biotech.

【Caption 2】Dr. Tessie Che, Chairperson & General Manager of Amaran Biotech, delivers her acceptance speech.

【Caption 3】Amaran Biotech earns the Taiwan Biopharma Excellence Award for its advanced fully automated robotic aseptic filling line.

【Caption 4】Amaran Biotech’s fully automated aseptic filling line delivers high-quality, low-waste filling solutions.